版权说明 操作指南
首页 > 成果 > 详情

Cardiovascular protective effects of GLP-1: a focus on the MAPK signaling pathway

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zhao, Yu-Yan;Chen, Lin-Hui;Huang, Liang;Li, Yong-Zhen;Yang, Chen;...
通讯作者:
Zhang, C
作者机构:
[Yang, Chen; Li, Yong-Zhen; Qu, Shun-Lin; Zhang, Chi; Zhao, Yu-Yan; Chen, Lin-Hui] Univ South China, Hengyang Med Coll, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China.
[Huang, Liang] Univ South China, Hengyang Med Coll, Res Lab Translat Med, Hengyang 421001, Hunan, Peoples R China.
[Zhu, Ying] Univ South China, Coll Publ Hlth, Dept Hlth Inspect & Quarantine, Hengyang 421001, Hunan, Peoples R China.
通讯机构:
[Zhang, C ] U
Univ South China, Hengyang Med Coll, Inst Cardiovasc Dis, Key Lab Arteriosclerol Hunan Prov, Hengyang 421001, Hunan, Peoples R China.
语种:
英文
关键词:
glucagon-like peptide 1;type 2 diabetes;mitogen-activated protein kinase pathway;cardiovascular disease;peptide GLP-1;diabète de type2;voie de la MAPK;maladies cardiovasculaires
期刊:
BIOCHEMISTRY AND CELL BIOLOGY
ISSN:
0829-8211
年:
2022
卷:
100
期:
1
页码:
9-16
基金类别:
National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100106, 81670424]; Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [2021JJ30602]; International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province [2018WK4031]; Outstanding Youth Project by Scientific Research Fund of Hunan Provincial Education Department [19B478]; Scientific Research Foundation for Doctor of University of South China [2012XQD37, 2017XQD04]; Scientific Research Foundation for the Returned Overseas Scholars of University of South ChinaScientific Research Foundation for the Returned Overseas Chinese Scholars [2017XQD29]
机构署名:
本校为第一且通讯机构
院系归属:
医学院
公共卫生学院
摘要:
Cardiovascular and related metabolic diseases are significant global health challenges. Glucagon-like peptide 1 (GLP-1) is a brain-gut peptide secreted by the ileal endocrine system and is now an established drug target in type 2 diabetes (T2DM). GLP-1 targeting agents have been shown not only to treat T2DM, but also to exert cardiovascular protective effects by regulating multiple signaling pathways. The mitogen-activated protein kinase (MAPK) pathway, a common signal transduction pathway for transmitting extracellular signals to downstream ef...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com